• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MacDermid Incorporated

MacDermid Incorporated

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)

    Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)

  2. bluebird bio Reports Second Quarter 2017 Financial Results and Recent Operational Progress

    bluebird bio Reports Second Quarter 2017 Financial Results and Recent Operational Progress

  3. Roth Conversion of Aftertax Money

    Natalie Choate answers reader questions about Roth conversion rules as they relate to inherited IRAs and profit-sharing plans.

1

©2017 Morningstar Advisor. All right reserved.